SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain



Status:Completed
Conditions:Back Pain
Therapuetic Areas:Musculoskeletal
Healthy:No
Age Range:25 - 70
Updated:5/3/2014
Start Date:October 2011
End Date:April 2016

Use our guide to learn which trials are right for you!

A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain

To evaluate the safety and efficacy of RF ablation using the Intracept Intraosseous Nerve
Ablation System to ablate intraosseous nerves for the relief of chronic axial low back pain.
This is a prospective, double-blind, randomized, sham-controlled clinical trial with an
optional crossover component.


Inclusion Criteria:

- Skeletally mature patients age 25 - 70 years, inclusive

- Chronic lower back pain for at least six (6) months

- Failure to respond to at least six (6) months of non-operative conservative
management. The minimum requirement is as follows:

- Analgesic therapy (minimum of 2 weeks) and a minimum of 4 weeks of NSAID therapy

- Supervised exercise program(minimum of 12 sessions)

- Oswestry Disability Index (ODI) at time of evaluation of at least 30 points

- Baseline Visual Analog Scale (VAS) of at least 4cm on a 10cm scale

- The following test indicating that the vertebral body is the source of pain:

1.MRI showing Type 1 or Type II Modic changes at least one vertebral endplate, at one
or more levels from L3 to S1

- Understands the local language and is willing and able to follow the requirements of
the protocol

- Understands the informed consent and signs the institutional review board/
independent ethics committee (IRB/IEC) approved informed consent form

Exclusion Criteria:

- Radicular pain by history or evidence of pain or neurological deficit in a dermatomal
zone at or below the medial thigh.

- Previous surgery performed on the lumbar spine

- History of symptomatic spinal stenosis

- History of osteoporotic or tumor-related vertebral body compression fracture

- History of vertebral cancer or spinal metastasis

- History of spinal infection

- Metabolic bone disease (e.g. osteogenesis imperfecta)

- BMI ≥40

- Osteoporosis, defined as T score <-2.5

- Any radiographic evidence of other important back pathology, such as:

1. Nerve root compression or severe effacement of the thecal sac that correlates
with radicular pain or muscle weakness

2. Disc extrusion or disc protrusion >5mm

3. Facet arthrosis or facet effusion at any lumbar level that correlates with
clinical evidence of facet mediated low back pain

4. Spondylolisthesis 2mm or greater at any level

5. Spondylolysis at any level

- MRI evidence of Modic changes, Type I or Type II at greater than 3 vertebral bodies.

- Any back pathology related to trauma, evidence of vertebral compression fracture or
other spinal pathology that could affect assessment of response to back pain

- Demonstrates 3 or more Waddell's signs of Inorganic Behavior

- Any evidence of current systemic infection

- Uncorrected bleeding diathesis

- Any neurologic problem that prevents early mobilization after surgery or interferes
with assessment of ODI

- Contraindication to MRI or patients who have allergies to the components of the
Intracept device

- Pregnant, lactating or plan to become pregnant in next year

- Diabetes requiring daily insulin

- Current use of steroid therapy, with the exception of inhalation steroids for asthma

- Evidence of mental instability or uncontrolled depression; patients requiring
anti-depressants or anti-psychotics within 3 months of enrollment are not eligible;
patients with a Beck Depression Score of greater than 24 are not eligible

- Receiving Workmen's Compensation

- Currently involved in litigation regarding back pain/injury or financial incentive to
remain impaired

- Any medical condition that impairs follow-up

- Contraindications to the proposed anesthetic protocol.

- Evidence of substance abuse; patients using prescribed extended release narcotics are
not eligible (e.g. fentanyl patch,MS contin, oxycontin)

- Known to require at the time of screening and/or randomization, additional surgery to
the lumbar spinal region within six months

- Being treated with radiation, chemotherapy, immunosuppression, or chronic steroid
therapy (prednisone use up to 5 mg/qd or its equivalent is allowed)

- Has a life expectancy of less than 1 year

- Has active implantable devices, such as cardiac pacemakers, spinal cord stimulators,
etc.

- Is a prisoner
We found this trial at
13
sites
Daly City, California 94015
?
mi
from
Daly City, CA
Click here to add this to my saved trials
Austin, Texas 78731
?
mi
from
Austin, TX
Click here to add this to my saved trials
Carmel, Indiana 46032
?
mi
from
Carmel, IN
Click here to add this to my saved trials
Charlotte, North Carolina 28207
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
Eugene, Oregon 97401
?
mi
from
Eugene, OR
Click here to add this to my saved trials
Long Beach, California 90806
?
mi
from
Long Beach, CA
Click here to add this to my saved trials
Marietta, Georgia 30060
?
mi
from
Marietta, GA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19107
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phoenix, Arizona 85020
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Richmond, Virginia 23235
?
mi
from
Richmond, VA
Click here to add this to my saved trials
Santa Monica, California 90404
?
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Scarborough, Maine 04074
?
mi
from
Scarborough, ME
Click here to add this to my saved trials
?
mi
from
Southfield, MI
Click here to add this to my saved trials